Allosteric regulation of glycogen synthase in liver. A physiological dilemma
Glycogen synthase catalyzes the transfer of the glucosyl moiety from UDP-glucose to the terminal branch of the glycogen molecule and is considered to be the rate-limiting enzyme for glycogen synthesis. However, under ideal assay conditions, i.e. 37 degrees C with saturating concentrations of UDP-glu...
Saved in:
Published in | The Journal of biological chemistry Vol. 268; no. 18; pp. 13286 - 13290 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Biochemistry and Molecular Biology
25.06.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Glycogen synthase catalyzes the transfer of the glucosyl moiety from UDP-glucose to the terminal branch of the glycogen molecule
and is considered to be the rate-limiting enzyme for glycogen synthesis. However, under ideal assay conditions, i.e. 37 degrees
C with saturating concentrations of UDP-glucose and the activator, glucose-6-P, the maximal catalytic activity of glycogen
synthase was only 78% of the in vivo glycogen synthetic rate. Using concentrations of UDP-glucose and glucose-6-P likely to
be present in vivo, the rate was only approximately 30%. This prompted us to reassess a possible role of allosteric effectors
on synthase activity. Glycogen synthase was assayed at 37 degrees C using dilute, pH 7.0, buffered extracts, initial rate
conditions, and UDP-glucose and glucose-6-P concentrations, which approximate those calculated to be present in total liver
cell water. Several allosteric effectors were tested. Magnesium and AMP had little effect on activity. Pi, ADP, ATP, and UTP
inhibited activity. When a combination of effectors were added at concentrations approximating those present in cell water,
synthase activity could account for only 2% of the glycogen synthetic rate. Thus, although allosteric effectors are likely
to be playing a major role in regulating synthase enzymic activity in liver cells, to date, a metabolite that can stimulate
activity and/or overcome nucleotide inhibition has yet to be identified. If such a metabolite cannot be identified, an additional
or alternative pathway for glycogen synthesis must be considered. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1016/S0021-9258(19)38650-8 |